
JAMA Clinical Reviews
JAMA NetworkAudio
- Format:
- Podcast
- New episodes:
- Weekly
- Typical length:
- about 20 minutes
- Latest episode:
About this show
Author interviews that explore the latest clinical reviews.
Covers: clinical medicine, medical research, neurology, cardiology, vaccines, infectious disease, pharmacology, pediatrics, public health
Show details and episodes come from the publisher's public feed at rss.libsyn.com. Last updated . Names, artwork and text belong to their publishers.
Recently on this show
Summary of recent episodes, drawn from the publisher's feed.
This podcast features interviews with authors of medical review articles from JAMA, discussing diagnosis and treatment across medicine. Recent episodes cover ischemic stroke, childhood obesity, narcolepsy, heart transplantation, and respiratory virus vaccines.
Cosmos
Rated alike
- Techquickie
Often rated the same way. - ThatClutchGuy
Often rated the same way. - The Clinical Problem Solvers
Often rated the same way.
Similar in subject
- JAMA Medical News
Both cover: pediatrics, medical research, clinical medicine - Cram The Pance
Both cover: pediatrics, clinical medicine, pharmacology - Circulation on the Run
Both cover: medical research, clinical medicine, cardiology
Similar shows
Explore more
Episodes
Medications for Opioid Use Disorder, Withdrawal, and Overdose
· 23 min
Opioid use disorder is the third most prevalent substance use disorder worldwide. Author Alexander Walley, MB, MSc, of Boston Medical Center and Boston University joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the efficacy, safety, and practical considerations of treating patients with medications for opioid use disorder, opioid withdrawal, and opioid overdose. Related Content: - Medications for Opioid Use Disorder, Opioid Withdrawal, and Opioid Overdose
Not rated yetOvarian Cancer Prevention With Opportunistic Fallopian Tube Removal
· 17 min
Ovarian cancer may be prevented with removal of the fallopian tubes during pelvic or select abdominal surgery in eligible women. This procedure, opportunistic salpingectomy, can be offered to more eligible women. Author Jurgen M. Piek, MD, PhD, of the Catharina Cancer Institute discusses this and more with JAMA Deputy Editor Linda Brubaker, MD, MS. Related Content: - Opportunistic Salpingectomy for Prevention of Tubo-Ovarian Carcinoma
Not rated yetIgA Nephropathy in Adults
· 27 min
IgA nephropathy is a chronic kidney disease involving deposition of IgA-containing immune complexes in the glomerulus, which often causes kidney failure within 10 to 20 years. Author Michelle Marie O'Shaughnessy, MB, BCh, BAO, MS, of Galway University joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the symptoms, risk factors, diagnosis, treatment, and prognosis of IgA nephropathy in adults. Related Content: - IgA Nephropathy in Adults
Not rated yetRestless Legs Syndrome
· 23 min
Restless legs syndrome is a sleep-related neurologic disorder that causes an overwhelming urge to move the limbs, which can cause substantial sleep disturbance. Author John W. Winkelman, MD, PhD, of Harvard Medical School joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the symptoms, risk factors, diagnosis, and treatment of restless legs syndrome. Related Content: - Restless Legs Syndrome
Not rated yetA Conversation About the FDA's Regulation of Mifepristone
· 20 min
Mifepristone used with misoprostol is the most common abortion regimen in the US. It is also a focal point of reproductive health policy and politics, with controversy over its legal status and regulation by the US Food and Drug Administration (FDA). Author G. Caleb Alexander, MD, MS, from Johns Hopkins discusses this and more with JAMA Deputy Editor Joseph S. Ross, MD, MHS. Related Content: - The US Food and Drug Administration's Regulation of Mifepristone - Politics, Science, and the Future of FDA Drug Regulation
Not rated yetGastric Cancer Worldwide
· 13 min
Incidence rates of gastric cancer in younger individuals are on the rise and gastric cancer is the fifth-leading cause of cancer-related deaths worldwide. JAMA Review author Haeseong Park, MD, MPH, from the Dana Farber Cancer Institute, discusses this and more with JAMA Senior Editor Karen Lasser, MD, MPH. Related Content: - Gastric Cancer
Not rated yetJAMA Editors' Choice 2025: Clinical Reviews Podcasts
· 16 min
JAMA Deputy Editor Mary McDermott, MD, and JAMA Deputy Editor Kristin Walter, MD, MS, highlight their selections of top JAMA Clinical Reviews podcasts in 2025. Related Content: - Managing Adverse Effects of Obesity Medications - Diagnosis and Management of Hypothyroidism - Type 2 Diabetes: Diagnosis and Current Guidelines for Treatment - Managing Adverse Effects of Incretin-Based Medications for Obesity - Hypothyroidism - Diagnosis and Treatment of Type 2 Diabetes in Adults - JAMA Editors' Choice 2024: Clinical Reviews Podcasts
Not rated yetFrom the JAMA Network: JAMA Research of the Year With Editor in Chief Kirsten Bibbins-Domingo
· 16 min
In this episode, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Medical News Director Jennifer Abbasi discuss the journal's inaugural Research of the Year roundup. Related Content: - Research of the Year 2025
Not rated yetWHO Guideline on the Use and Indications of GLP-1 Therapies for the Treatment of Obesity in Adults
· 33 min
Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, relapsing disease. WHO recently published a guideline in JAMA on the use and indications of GLP-1 therapies for the treatment of #obesity in adults. Francesca Celletti, MD, PhD, and Ezekiel Emanuel, MD, PhD, join JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss. Related Content: - World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults
Not rated yetHead and Neck Cancer
· 18 min
Head and neck cancer is the seventh most common cancer worldwide and is commonly associated with tobacco and alcohol use, or human papillomavirus (HPV) infection. Author Lara Dunn, MD, of Memorial Sloan Kettering Cancer Center joins JAMA Associate Editor Margaret Wheeler, MD, to discuss the epidemiology, risk factors, diagnosis, treatment, and prognosis of head and neck cancer. Related Content: - Head and Neck Cancer
Not rated yet